[Federal Register Volume 62, Number 152 (Thursday, August 7, 1997)]
[Notices]
[Pages 42586-42587]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-20857]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Cancer Institute Special Emphasis Panel (SEP) meeting:

    Name of SEP: Phase II Clinical Trials of New Chemopreventive 
Agents.
    Date: August 12-13, 1997.
    Time: 8 a.m. to 5 p.m.
    Place: National Cancer Institute, Executive Plaza North, 
Conference Room G, 6130 Executive Boulevard, Bethesda, MD 20892.

[[Page 42587]]

    Contact Person: Wilna Woods, Ph.D., Scientific Review 
Administrator, National Cancer Institute, NIH, Executive Plaza 
North, Room 622B, 6130 Executive Boulevard, MSC 7410, Bethesda, MD 
20892-7410, Telephone: 301/496-7903.
    Purpose/Agenda: To evaluate and review responses to Request for 
Proposal.
    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the review and funding cycle.
    The meeting will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C. Proposals 
and the discussions could reveal confidential trade secrets or 
commercial property such as patentable material and personal 
information concerning individuals associated with the proposals, 
the disclosure of which would constitute a clearly unwarranted 
invasion of personal privacy.

(Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
Cancer Research Manpower; 93.399, Cancer Control)

    Dated: July 31, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, National Institute of Health.
[FR Doc. 97-20857 Filed 8-6-97; 8:45 am]
BILLING CODE 4140-01-M